News
The general manager of Bioiberica highlighted his companys commitment to a comprehensive approach to the treatment of osteoarthritis: prevention, chondroprotector drugs, and personalized medicine. Together, all these elements improve the patients quality of life.
The La mañana de la 1 program, broadcast by Televisión Española (TVE), devoted its saber vivir health section to the treatment of osteoarthritis.
The 19th edition of the symposium on glyccosaminoglyccans New developments of anticoagulant and non-anticoagulant glycosaminoglycans and of other coagulation inhibitors, is the most important meeting dealing with glycosaminoglycans. It will be held on 22-24 September 2011 at Villa Vigoni (Loveno, Lake Como)
Bioiberica has recently formed a German subsidiary, BIOIBERICA GmbH, headed up by Mr Axel Schmidt.
Bioiberica has followed a vertical integration strategy in the last three years towards the development and sale of finished products. All products undergo scientific and clinical development and have their own marketing strategy to support sales in each country.